Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
Inv. presentation
CC transcript
REGENERON PHARMACEUTICALS, INC. (REGN) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/13/2023 144 Form 144 - Report of proposed sale of securities:
10/05/2023 8-K Results of Operations and Financial Condition  Interactive Data
10/03/2023 144 Form 144 - Report of proposed sale of securities:
10/02/2023 144 Form 144 - Report of proposed sale of securities:
09/27/2023 SC 13D/A REGENERON PHARMACEUTICALS, INC. reports a 100% stake in Decibel Therapeutics, Inc.
08/25/2023 SC TO-T Form SC TO-T - Tender offer statement by Third Party:
08/24/2023 144 Form 144 - Report of proposed sale of securities:
08/23/2023 144 Form 144 - Report of proposed sale of securities:
08/23/2023 144 Form 144 - Report of proposed sale of securities:
08/22/2023 144 Form 144 - Report of proposed sale of securities:
08/21/2023 144 Form 144 - Report of proposed sale of securities:
08/18/2023 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
08/10/2023 144 Form 144 - Report of proposed sale of securities:
08/09/2023 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party:
08/03/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/03/2023 8-K Quarterly results
Docs: "Regeneron Reports Second Quarter 2023 Financial and Operating Results"
08/01/2023 144 Form 144 - Report of proposed sale of securities:
07/03/2023 144 Form 144 - Report of proposed sale of securities:
07/03/2023 144 Form 144 - Report of proposed sale of securities:
06/01/2023 144 Form 144 - Report of proposed sale of securities:
05/18/2023 PX14A6G Form PX14A6G - Notice of exempt solicitation submitted by non-management:
05/04/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/04/2023 8-K Quarterly results
04/21/2023 144 Form 144 - Report of proposed sale of securities:
04/21/2023 ARS Form ARS - Annual Report to Security Holders:
04/21/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/21/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/17/2023 8-K Quarterly results
03/29/2023 8-K Quarterly results
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2023 SC 13G/A FMR LLC reports a 10.4% stake in REGENERON PHARMACEUTICALS INC
02/09/2023 SC 13G/A VANGUARD GROUP INC reports a 8.2% stake in Regeneron Pharmaceuticals Inc.
02/06/2023 10-K Annual Report for the period ended December 31, 2022
02/03/2023 SC 13G/A BlackRock Inc. reports a 8.6% stake in REGENERON PHARMACEUTICALS INC
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy